CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 2, March/April 2014
66
AFRICA
with Behçet’s disease.
Ann Rheum Dis
1995;
54
: 610.
7.
Önder M, Gürer MA. Behçet’s disease: an enigmatic vasculitis.
Clin
Dermatol
1999;
17
: 571–576.
8.
Direskeneli H, Hasan A, Shinnick T,
et al
. Recognition of B cell
epitopes of the 65 kd HSP in Behçet’s disease.
Scand J Immunol
1996;
43
: 464–471.
9.
Park JH, Han MC, Bettmann MA. Arterial manifestations of Behçet
disease.
Am J Roentgenol
1984;
143
: 821–825.
10. Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet disease (Behçet
syndrome).
Semin Arthritis Rheum
1979;
8
: 223–260.
11. Marzban M, Mandegar MH, Karimi A,
et al
. Cardiac and great vessel
involvement in ‘Behcet’s disease.
J Cardiac Surg
2008;
23
(6): 765–768.
12. International study group for Behçet’s disease.
Lancet
1990;
335
:
1078–1080.
13. Gülbay B, Acican T, Erçen Diken Ö, Pinar Önen Z. Familial Behçet’s
disease of adult age: a report of 4 cases from a Behçet family.
Intern
Med
2012;
51
(12): 1609–1611.
14. Yilmaz S, Cimen KA. Familial Behçet’s disease.
Rheumatol Int
2010;
30
: 1107–1109.
15. Baharav E, Weinberger A. The HLA-B*5101 molecule-binding capac-
ity to antigens used in animal models of Behçet’s disease: a bioinfor-
matics study.
Med Assoc J
2012;
14
(7): 424–428.
16. Chang J-E, Lee Y-H, Lee J. Multiple cardiovascular complications
in a patient with Behcet’s disease.
Korean J Intern Med
2008;
23
(2):
100–102.
17. Sengül N, Demirer S, Yerdel MA, Terzio
ğ
lu G, Akin B, Gürler A,
et al
.
Comparison of coagulation parameters for healthy subjects and Behçet
disease patients with and without vascular involvement.
World J Surg
2000;
24
(12): 1584–1588.
18. Ludwig J, Hashimoto E, McGill DB, van Heerden JA. Classification
of hepatic venous outflow obstruction: ambiguous terminology of the
Budd-Chiari syndrome.
Mayo Clin Proc
1990;
65
(1): 51–55.
19. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for
Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of
the inferior vena cava at its hepatic portion.
Hepatology
1998;
28
(5):
1191–1198.
20. Lee YJ, Kang SW, Yang JI, Choi YM, Sheen D, Lee EB,
et al
.
Coagulation parameters and plasma total homocysteine levels in
Behcet’s disease.
Thromb Res
2002;
106
(1): 19–24.
21. Ozatli D, Sayinalp N, Büyüka
ş
ikY, Karaku
ş
S, Haznedaroglu IC, Kirazli
S,
et al.
Unchanged global fibrinolytic capacity despite increased factor
VIIa activity in Behçet’s disease: evidence of a prethrombotic state.
Rheumatol Int
2002;
21
(4): 137–140.
22. Hamza M. Large artery involvement in Behçet’s disease.
J Rheumatol
1987;
14
(3): 554–559.
23. Raza K, Thambyrajah J, Townend JN, Exley AR, Hortas C, Filer A,
et
al
. Suppression of inflammation in primary systemic vasculitis restores
vascular endothelial function: lessons for atherosclerotic disease?
Circulation
2000;
102
: 1470–1472.
24. Yoon NS, Lee SR, Kim KH, Hong YJ, Park HW, Kim JH,
et al
. Carotid
artery intima–media thickness in Behcet’s disease patients without
significant cardiovascular involvement.
Korean J Intern Med
2008;
23
(2): 87–93.
25. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Rönnemaa
T,
et al
. Interrelations between brachial endothelial function and carotid
intima-media thickness in young adults: the cardiovascular risk in
young Finns study.
Circulation
2004;
110
(18): 2918–2923.
26. Hong SN, Park JC, Yoon NS,
et al.
Carotid artery intima-media thick-
ness in Behcet’s disease patients without significant cardiovascular
involvement.
Korean J Int Med
2008;
23
(2); 87–93.
27. Balik OL, Gur G, Lenk N, Artuz F, Alli N. Serum lipoprotein (a) levels
and Behçet’s disease: is there an association?
Int J Dermatol
2007;
46
(8): 827–829.
28. Rhee MY1, Chang HK, Kim SK. Intima–media thickness and arterial
stiffness of carotid artery in Korean patients with Behçet’s disease.
J
Korean Med Sci
2007;
22
(3): 387–392.
29. Lee CW, Lee JS, Lee WK,
et al
. Aortic valve involvement in Behcet’s
disease. A clinical study of 9 patients.
Korean J Intern Med
2002;
17
(1): 51–56.
